Autolus Therapeutics plc ADR (AUTL) concluded trading on Wednesday at a closing price of $7.25, with 3.77 million shares of worth about $27.33 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 163.64% during that period and on Wednesday the price saw a gain of about 5.84%. Currently the company’s common shares owned by public are about 173.07M shares, out of which, 149.01M shares are available for trading.
Stock saw a price change of 14.72% in past 5 days and over the past one month there was a price change of 0.55%. Year-to-date (YTD), AUTL shares are showing a performance of 12.58% which increased to 262.50% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.61 but also hit the highest price of $7.45 during that period. The average intraday trading volume for Autolus Therapeutics plc ADR shares is 1.60 million. The stock is currently trading 17.90% above its 20-day simple moving average (SMA20), while that difference is up 23.86% for SMA50 and it goes to 99.90% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Autolus Therapeutics plc ADR (NASDAQ: AUTL) currently have 173.07M outstanding shares and institutions hold larger chunk of about 54.54% of that.
The stock has a current market capitalization of $1.26B and its 3Y-monthly beta is at 1.92. It has posted earnings per share of -$0.98 in the same period. It has Quick Ratio of 8.16 while making debt-to-equity ratio of 0.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AUTL, volatility over the week remained 10.54% while standing at 8.90% over the month.
Analysts are in expectations that Autolus Therapeutics plc ADR (AUTL) stock would likely to be making an EPS of $Autolus Therapeutics plc in the current quarter, while forecast for next quarter EPS is $7.25 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $UNITIL Corporation which is $CIA MINERA AUTLAN SAB DE CV at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Artelo Biosciences, Inc. in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 35.79% while it is estimated to increase by 24.83% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Deutsche Bank on November 09, 2023 offering a Buy rating for the stock and assigned a target price of $10 to it.
